![clinical trials](https://veille-cyber.com/wp-content/uploads/2023/06/clinical-trials-326x245.jpg)
The first fully AI-generated drug enters clinicaltrials in human patients
Insilico Medicine, a Hong Kong-based biotech startup with more than $400 million in funding, created the drug as a treatment for idiopathic pulmonary fibrosis, a [… Read more ]